Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin is the key factor in elevated plasma growth differentiation factor‐15 levels in type 2 diabetes: A nested, case–control study
Andrea Natali, Lorenzo Nesti, Elena Venturi, et al.
Diabetes Obesity and Metabolism (2018) Vol. 21, Iss. 2, pp. 412-416
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Cellular and Molecular Mechanisms of Metformin Action
Traci E. LaMoia, Gerald I. Shulman
Endocrine Reviews (2020) Vol. 42, Iss. 1, pp. 77-96
Open Access | Times Cited: 516
Metformin: update on mechanisms of action and repurposing potential
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 460-476
Open Access | Times Cited: 326
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease
Dongdong Wang, Emily A. Day, Logan K. Townsend, et al.
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 10, pp. 592-607
Closed Access | Times Cited: 315
Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss
Emily A. Day, Rebecca J. Ford, Brennan K. Smith, et al.
Nature Metabolism (2019) Vol. 1, Iss. 12, pp. 1202-1208
Closed Access | Times Cited: 248
GDF15, an emerging key player in human aging
Maria Conte, Cristina Giuliani, Antonio Chiariello, et al.
Ageing Research Reviews (2022) Vol. 75, pp. 101569-101569
Open Access | Times Cited: 89
Circulating growth differentiation factor‐15 levels are associated with early echocardiographic signs of diastolic function impairment in the STANISLAS cohort: A 20‐year follow‐up study
Luca Monzo, Constance Xhaard, João Pedro Ferreira, et al.
European Journal of Heart Failure (2025)
Closed Access | Times Cited: 5
Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells
Ming Yang, Tamana Darwish, Pierre Larraufie, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 75
Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?
Moein Ala, Mahan Ala
ACS Pharmacology & Translational Science (2021) Vol. 4, Iss. 6, pp. 1747-1770
Open Access | Times Cited: 63
Metabolic Action of Metformin
Izabela Szymczak-Pajor, Sylwia Wenclewska, Agnieszka Śliwińska
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 810-810
Open Access | Times Cited: 49
Metformin triggers a kidney GDF15-dependent area postrema axis to regulate food intake and body weight
Song‐Yang Zhang, Kyla Bruce, Zahra Danaei, et al.
Cell Metabolism (2023) Vol. 35, Iss. 5, pp. 875-886.e5
Open Access | Times Cited: 37
Echocardiographic and biomarker characteristics in diabetes, coronary artery disease or both: insights from HOMAGE trial
Luca Monzo, Masatake Kobayashi, João Pedro Ferreira, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Pharmacology of metformin – An update
Hartmut Glossmann, O. Lutz
European Journal of Pharmacology (2019) Vol. 865, pp. 172782-172782
Closed Access | Times Cited: 55
Disease-specific plasma levels of mitokines FGF21, GDF15, and Humanin in type II diabetes and Alzheimer’s disease in comparison with healthy aging
Maria Conte, Jacopo Sabbatinelli, Antonio Chiariello, et al.
GeroScience (2020) Vol. 43, Iss. 2, pp. 985-1001
Open Access | Times Cited: 52
The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study
Shiu Lun Au Yeung, Shan Luo, C. Mary Schooling
Diabetologia (2019) Vol. 62, Iss. 9, pp. 1638-1646
Open Access | Times Cited: 51
Growth differentiation factor‐15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program
João Pedro Ferreira, Milton Packer, Javed Butler, et al.
European Journal of Heart Failure (2023) Vol. 26, Iss. 1, pp. 155-164
Open Access | Times Cited: 15
<p>Metformin Activates the AMPK-mTOR Pathway by Modulating lncRNA <em>TUG1</em> to Induce Autophagy and Inhibit Atherosclerosis</p>
Ganhua You, Xiangshu Long, Fang Song, et al.
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 457-468
Open Access | Times Cited: 36
GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
Jing Ouyang, Stéphane Isnard, John Lin, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 34
GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease
Qing-Ao Xiao, Qian He, Jun Zeng, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 146, pp. 112582-112582
Open Access | Times Cited: 32
The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat
Francis de Zegher, Marta Díaz, Joan Villarroya, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Serum growth differentiation factor 15 is associated with glucose metabolism in the third trimester in Chinese pregnant women
Mengyang Tang, Mingjuan Luo, Wenqian Lu, et al.
Diabetes Research and Clinical Practice (2019) Vol. 156, pp. 107823-107823
Open Access | Times Cited: 32
The association between serum growth differentiation factor-15 and 3-month depression after acute ischemic stroke
Xiurong Lu, Jinfeng Duan, Cheng Qian, et al.
Journal of Affective Disorders (2019) Vol. 260, pp. 695-702
Closed Access | Times Cited: 29
Circulating Cardiac Biomarkers in Diabetes Mellitus: A New Dawn for Risk Stratification—A Narrative Review
Alexander Е. Berezin, Alexander A. Berezin
Diabetes Therapy (2020) Vol. 11, Iss. 6, pp. 1271-1291
Open Access | Times Cited: 27
Oral lactate slows gastric emptying and suppresses appetite in young males
Mette Glavind Bülow Pedersen, Esben Søndergaard, Camilla Bak Nielsen, et al.
Clinical Nutrition (2021) Vol. 41, Iss. 2, pp. 517-525
Closed Access | Times Cited: 21
Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area
Giovanni Tulipano
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13068-13068
Open Access | Times Cited: 19
An investigation into the pleiotropic activity of metformin. A glimpse of haemostasis
Magdalena Markowicz-Piasecka, Adrianna Sadkowska, Kristiina M. Huttunen, et al.
European Journal of Pharmacology (2020) Vol. 872, pp. 172984-172984
Closed Access | Times Cited: 20
Page 1 - Next Page

Scroll to top